| Literature DB >> 30401822 |
Lei Wang1, Xulei Huang1, Anna Karen Carrasco Laserna1, Sam Fong Yau Li2,3.
Abstract
Triphenyl phosphate (TPHP) is one of the most highly utilized organophosphorus flame retardants, and has been frequently detected in various environmental matrices, including soil. So far, limited information is known regarding the potential toxicity of TPHP to the earthworm-soil ecosystem. We investigated the metabolism of TPHP and the perturbation of the endogenous metabolome in the earthworm, Perionyx excavatus, using gas chromatography mass spectrometry (GC-MS) and liquid chromatography quadrupole time-of-flight (LC-QTOF)-based untargeted metabolomics approach after acute exposure to TPHP for one and two days through a filter paper contact test, as well as after chronic exposure for 28 days in a soil microcosm experiment. TPHP showed low bioaccumulation potential in the earthworm-soil ecosystem at concentrations of 10 mg/kg and 50 mg/kg. Identified phase I metabolites include diphenyl phosphate, mono-hydroxylated and di-hydroxylated TPHP. Two groups of phase II metabolites, thiol conjugates (including mercaptolactic acid, cysteine, cysteinylglycine, and mercaptoethanol conjugates) and glucoside conjugates (including glucoside, glucoside-phosphate, and C14H19O10P conjugates), were putatively identified. Only acute TPHP exposure caused significant perturbations of the endogenous metabolome in earthworms, featuring fluctuations in amino acids, glucose, inosine and phospholipids. These results reveal novel phase II metabolism and toxicity of TPHP in P. excavatus.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30401822 PMCID: PMC6219545 DOI: 10.1038/s41598-018-34814-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Concentrations of TPHP (A) in soil with and without earthworms through 28 days and (B) in earthworms after acute and chronic exposure on a dry weight basis. Note that acute and chronic exposures refer to filter paper and soil experiments, respectively. In acute exposure, the 1/10 LC50 and 1/5 LC50 concentrations equal to 0.425 and 0.85 μg/cm2, respectively. Data is shown with mean and associated standard derivation.
Identified TPHP metabolites in earthworms from LC-QTOF spectra after 28 days of TPHP exposure in soil.
| Type | Metabolites | Adducts | Formula | Theoretical | Experimental | Mass error (ppm) | Theoretical isotope ratio (%) | Experimental isotope ratio (%) | Retention time (min) | Characteristic product ions |
|---|---|---|---|---|---|---|---|---|---|---|
| phase I metabolites | DPHP | [M + H]+ | C12H12O4P1 | 251.0468 | 251.0458 | 3.7 | 13.6 | 13.5 | 10.52 | 152.0608, 175.0128, 215.0245, 233.0353 |
| OH-TPHP (3 isomers) | [M + H]+ | C18H16O5P1 | 343.0730 | 343.0726 | 1.2 | 20.4 | 19.5 | 12.27, 13.95, 16.72 | 152.0608, 215.0245, 233.0353, 357.0335 | |
| [M-H]− | C18H14O5P1 | 341.0584 | 341.0596 | 3.3 | 20.4 | 20.6 | 13.49, 16.71, 17.10 | 93.0345, 185.0614, 233.0383, 249.0347 | ||
| di-OH-TPHP (4 isomers) | [M + H]+ | C18H16O6P1 | 359.0679 | 359.0680 | 0.2 | 20.4 | 19.5 | 12.85, 13.07, 13.43, 16.22 | 153.0709, 215.0245, 233.0353, 251.0456 | |
| thiol conjugates | mercaptolactic acid-TPHP (3 isomers) | [M + H]+ | C21H20O7S1P1 | 447.0662 | 447.0656 | 1.3 | 24.6 | 22.6 | 13.14, 13.94, 16.24 | 152.0608, 215.0245, 233.0353, 357.0335 |
| [M + NH4]+ | C21H23O7N1S1P1 | 464.0927 | 464.0925 | 0.5 | 25.0 | 30.0 | 12.08, 13.91, 16.25 | 152.0608, 215.0245, 233.0353, 357.0335 | ||
| [M-H]− | C21H18O7S1P1 | 445.0516 | 445.0518 | 0.4 | 24.6 | 24.6 | 13.38,15.64 | 177.0355, 249.0347, 267.1975, 357.0363 | ||
| cysteine-TPHP (2 isomers) | [M + H]+ | C21H21O6N1S1P1 | 446.0822 | 446.0813 | 2.0 | 25.0 | 23.8 | 12.05, 13.15 | 152.0608, 215.0245, 233.0353, 357.0335 | |
| cysteinylglycine-TPHP (2 isomers) | [M + H]+ | C23H24O7N2S1P1 | 503.1036 | 503.1028 | 1.7 | 27.6 | 30.5 | 11.85, 12.80 | 152.0608, 215.0245, 233.0353, 357.0335 | |
| mercaptoethanol-TPHP (2 isomers) | [M + H]+ | C20H20O5S1P1 | 403.0764 | 403.0762 | 0.1 | 23.4 | 25.1 | 14.69, 17.45 | 152.0608, 215.0245, 233.0353, 357.0335 | |
| glutathione-TPHP | [M+H]+ | C28H31O10N3P1S1 | 632.1462 | 632.1444 | 2.9 | 33.7 | 30.5 | 13.06 | — | |
| glucoside conjugates | glucoside-TPHP | [M+NH4]+ | C24H29O10N1P1 | 522.1524 | 522.1511 | 2.4 | 27.8 | 24.4 | 13.55 | 343.0732 |
| [M+COOH]− | C25H26O12P1 | 549.1167 | 549.1186 | 3.4 | 28.5 | 27.6 | 13.57 | 233.0366, 249.0330, 341.0598, 503.1092 | ||
| phosphate-glucoside-TPHP | [M+H]+ | C24H27O13P2 | 585.0921 | 585.0911 | 1.8 | 27.5 | 23.7 | 13.11 | 343.0732 | |
| [M-H]− | C24H25O13P2 | 583.0776 | 583.0786 | 1.7 | 27.5 | 27.5 | 12.66 | 78.9586, 241.0018, 291.0917, 537.3042 | ||
| C14H19O10P-TPHP (3 isomers) | [M+H]+ | C32H33O14P2 | 703.1340 | 703.1327 | 1.9 | 36.5 | 34.8 | 15.67, 16.31 | 91.0534, 127.0385, 263.0913, 343.0732 | |
| [M-H]− | C32H31O14 P2 | 701.1195 | 701.1221 | 3.8 | 36.5 | 35.0 | 14.66, 15.16 | 78.9586, 223.0013, 359.0560, 583.0755 | ||
| [M+NH4]+ | C32H36O14N1P2 | 720.1606 | 720.1578 | 3.9 | 36.9 | 39.2 | 14.72, 14.95, 16.30 | 127.0385, 263.0913, 343.0732, 703.1316 | ||
| C14H19O10P-TPHP-OH (3 isomers) | [M+H]+ | C32H33O15P2 | 719.1289 | 719.1271 | 2.6 | 36.5 | 38.1 | 14.13, 14.72, 16.24 | 107.0478, 279.0848, 343.0732, 469.1023 | |
| [M-H]− | C32H31O15P2 | 717.1144 | 717.1175 | 4.3 | 36.5 | 37.0 | 13.46, 13.98, 15.13 | 78.9586, 359.0560 |
The structure of C14H19O10P could not be unambiguously identified by MS/MS spectra, and are tentatively proposed in Supplementary Fig. S2.
Figure 2MS/MS spectrum of (A) cysteine-TPHP (m/z 446.0811 in ESI+) and (B) glucoside-TPHP (m/z 549.1181 in ESI-) with annotation of the fragments. M refers to the intact metabolite.
Cross validation results of partial least squares discriminant analysis model from LC-QTOF and GC-MS spectra after acute and chronic exposure using two components.
| Exposure | Spectra | Accurary | R2 | Q2 | Groups |
|---|---|---|---|---|---|
| acute exposure | LC-QTOF positive mode | 0.96 | 0.95 | 0.79 | Control versus Exposure |
| GC-MS | 0.85 | 0.83 | 0.40 | Control day2 versus 1/5LC50 day2 | |
| chronic exposure | LC-QTOF positive mode | 0.26 | 0.77 | −0.35 | Control versus 10 mg/kg versus 50 mg/kg |
| LC-QTOF positive mode | 0.65 | 0.78 | −0.02 | Control versus Exposure | |
| LC-QTOF negative mode | 0.30 | 0.81 | −0.20 | Control versus 10 mg/kg versus 50 mg/kg | |
| LC-QTOF negative mode | 0.61 | 0.84 | 0.01 | Control versus Exposure | |
| GC-MS | 0.52 | 0.85 | 0.44 | Control versus 10 mg/kg versus 50 mg/kg | |
| GC-MS | 0.74 | 0.74 | 0.17 | Control versus Exposure |
Figure 3Score plot of partial least squares discriminant analysis using features from (A) LC-QTOF spectra (Control versus Exposure) and (B) GC-MS spectra (control-day 2 versus 1/5 LC50-day2) after acute exposure.
Differentiating metabolites after acute exposure identified from GC-MS and LC-QTOF spectra.
| Metabolite | Retention time (min) | Spectra |
| VIP | p value |
|---|---|---|---|---|---|
| asparagine | 18.64 | GC-MS | — | 4.40 | 0.0008 |
| leucine | 12.07 | GC-MS | — | 3.58 | 0.0034 |
| lysine | 19.23 | GC-MS | — | 8.06 | 0.0090 |
| phenylalanine | 17.92 | GC-MS | — | 9.99 | 0.0118 |
| proline | 16.32 | GC-MS | — | 11.33 | 0.0180 |
| serine | 13.61 | GC-MS | — | 5.21 | 0.0184 |
| threonine | 14.07 | GC-MS | — | 4.30 | 0.0053 |
| valine | 11.02 | GC-MS | — | 6.28 | 0.0104 |
| glucose | 22.23 | GC-MS | — | 3.50 | 0.0054 |
| inosine | 29.76 | GC-MS | — | 6.26 | 0.0107 |
| PE(P-16:0/0:0) | 18.70 | LC-QTOF positive mode | 438.2969 | 2.23 | 0.0263 |
| PC(P-14:0/0:0) | 19.78 | LC-QTOF positive mode | 452.3124 | 3.53 | 0.0105 |
| PC(O-15:0/O-0:0) | 21.02 | LC-QTOF positive mode | 468.3429 | 2.42 | 0.0077 |
| PC(O-16:1/1:0) | 18.73 | LC-QTOF positive mode | 494.3588 | 1.84 | 0.0094 |
| PC(O-16:0/1:0) | 20.42 | LC-QTOF positive mode | 496.3025 | 1.71 | 0.0259 |
| PC(O-15:0/24:6) | 27.09 | LC-QTOF positive mode | 736.5259 | 1.79 | 0.0123 |
| PC(O-15:0/24:5) | 24.53 | LC-QTOF positive mode | 738.5407 | 1.74 | 0.0077 |
Figure 4Fold changes of differentiated metabolites after acute TPHP expousre: (A) asparagine, (B) leucine, (C) lysine, (D) phenylalanine, (E) proline, (F) serine, (G) threonine, (H) valine, (I) glucoside, (J) inosine and (K) phospholipids. For A-J, fold changes were calculated by dividing the peak areas of the exposure groups with the mean peak area of the control group for the same day from the GC-MS chromatograms. For phospholipids, control group, “Control” refers to control-day 1 and day 2 samples, whereas “Exposure” refers to the pool of the rest of the samples, and fold changes were calculated by dividing peak area in “Exposure” with mean peak area in “Control”. Data are shown as mean ± standard deviation. Significantly different levels compared with related control are labeled with an asterisk (at P < 0.05) or two asterisks (at P < 0.01) based on a two-tailed student t-test.